Procurement Summary
Country : USA
Summary : Assessment of African Green Monkeys as a Large Animal Model for Hantavirus Infections
Deadline : 20 Mar 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 116300330
Document Ref. No. : HT9425-25-RFI-TJB-01
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Summary: This RFI/SS is issued solely for information and planning purposes and shall not be construed as a solicitation, restrict the Government as to the ultimate acquisition approach, or serve as an obligation on the part of the Government. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are advised that the United States Government will not pay for any information or administrative costs incurred in response to this RFI. All costs associated with responding to this RFI/SS will be solely at the interested responder-s expense. Not responding to this RFI/SS does not preclude participation in any future Request for Proposal, if any is issued. No evaluation letters and/or results will be issued to Responders responding to this RFI/SS.
The information resulting from this RFI/SS will determine interest and capabilities available in the marketplace; and will assist in developing acquisition strategy.
Background/Scope: The United States Air Force 59th Medical Wing, Science and Technology Office has a requirement for research and development services to establish the African Green Monkey (AGM) as a viable animal model for studying orthohantavirus infection to allow for a thorough understanding of the disease pathogenesis as well as serving as a model to assess potential therapeutics.
Orthohantaviruses are emerging pathogens whose high mortality rates make them a potential biosecurity threat. These ribonucleic acid viruses are predominantly transmitted to humans via rodent hosts and primarily infect microvascular endothelial cells and have the capability to cause viral hemorrhagic fevers, including Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome. There are no current vaccines or therapeutics to prevent these viruses, primarily due to the lack of a reliable animal model. The African Green Monkey (AGM) has been a corner...
Active Contract Opportunity
Notice ID : HT9425-25-RFI-TJB-01
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE HEALTH AGENCY (DHA)
Office: ARMY MED RES ACQ ACTIVITY
General Information
Contract Opportunity Type: Sources Sought (Original)
Original Published Date: Mar 14, 2025 02:43 pm EDT
Original Response Date: Mar 20, 2025 10:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Apr 04, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: AC13 - NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; ExPERIMENTAL DEVELOPMENT
NAICS Code: 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Place of Performance: JBSA Lackland, Tx USA
Documents
Tender Notice